Close
Assistant Professor
Schmidt, Stephan
Positions
- Assistant Professor, Pharmaceutics , College of Pharmacy 2012 -
Overview
Affiliation
home department
- Pharmaceutics Academic Department
Publications
selected publications
-
academic article
- Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation. European Journal of Pharmaceutical Sciences. 2024
- Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates Less Than 29 Weeks' Gestation. Journal of Clinical Pharmacology. 2023
- Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug-Drug Interactions of Phenytoin. Pharmaceutics. 2023
- Modifiable statin characteristics associated with potential statin-related prescribing cascades. Pharmacotherapy. 2023
- Population pharmacokinetic and safety analysis of ropivacaine used for erector spinae plane blocks. Regional Anesthesia and Pain Medicine. 454-461. 2023
- Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies. CPT: pharmacometrics & systems pharmacology. 1016-1028. 2023
- Failure to predict amikacin elimination in critically ill patients with cancer based on the estimated glomerular filtration rate: applying PBPK approach in a therapeutic drug monitoring study. European journal of clinical pharmacology (Internet). 1003-1012. 2023
- High-throughput screening for prescribing cascades among real world statin initiators. Pharmacoepidemiology and Drug Safety. 773-782. 2023
- Barriers to global pharmacometrics: educational challenges and opportunities across the globe. CPT: pharmacometrics & systems pharmacology. 743-747. 2023
- Informing a Comprehensive Risk Assessment of Infant Drug Exposure From Human Milk: Application of a Physiologically Based Pharmacokinetic Lactation Model for Sotalol. Journal of Clinical Pharmacology. S106-S116. 2023
- PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris. CPT: pharmacometrics & systems pharmacology. 770-782. 2023
- The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies. CPT: pharmacometrics & systems pharmacology. 639-655. 2023
- Real-world effect of a potential drug-drug interaction between topiramate and oral contraceptives on unintended pregnancy outcomes. Contraception. 109953. 2023
- Exploring the Knowledge Gaps in Infant Drug Exposure From Human Milk: A Clinical Pharmacology Perspective. Journal of Clinical Pharmacology. 273-276. 2023
- Assessing the contribution of UGT isoforms on raltegravir drug disposition through PBPK modeling. European Journal of Pharmaceutical Sciences. 106309. 2022
- Application of physiologically based absorption and pharmacokinetic modeling in the development process of oral modified release generic products. European Journal of Pharmaceutics and Biopharmaceutics. 87-94. 2022
- In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida auris. Pharmaceutics. 2021
- Determining the Exposure Threshold for Levonorgestrel Efficacy Using an Integrated Model Based Meta-Analysis (MBMA) Approach. Clinical Pharmacology & Therapeutics. 2021
- Physiologically-based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition. Journal of Clinical Pharmacology. 2021
- Building optimal 3-drug combination chemotherapy regimens to eradicate Mycobacterium tuberculosis in its slow growth acid phase. Antimicrobial Agents and Chemotherapy. AAC0069321. 2021
- Application of a dual mechanistic approach to support bilastine dose selection for older adults. CPT: pharmacometrics & systems pharmacology. 2021
- Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation. Pharmaceutics. 2021
- In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris. Antibiotics (Basel). 2021
- Tribute to Professor Hartmut Derendorf - 1953 to 2020: Driving force in Clinical Pharmacology and Mentor Extraordinaire. Clinical Pharmacology & Therapeutics. 2021
- Dose-fractionation of moxifloxacin for the treatment of tuberculosis: impact of dosing interval and elimination half-life on microbial kill and resistance suppression. Antimicrobial Agents and Chemotherapy. 2021
- Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system. Contraception. 2020
- Establishment of a Disease-Drug Trial Model for Postmenopausal Osteoporosis: A Zoledronic Acid Case Study. Journal of Clinical Pharmacology. S86-S102. 2020
- Public Workshop Summary Report on FY2021 Generic Drug Regulatory Science Initiatives: Data analysis and model-based bioequivalence. Clinical Pharmacology & Therapeutics. 2020
- Quantitative assessment of levonorgestrel binding partner interplay and drug-drug interactions using physiologically based pharmacokinetic modeling. CPT: pharmacometrics & systems pharmacology. 2020
- A pharmacoepidemiologic approach to evaluate real-world effectiveness of hormonal contraceptives in the presence of drug-drug interactions. Epidemiology. 2020
- The Funnel: A screening technique for identifying optimal two-drug combination chemotherapy regimens. Antimicrobial Agents and Chemotherapy. 2020
- Quantitative Benefit-Risk Assessment of P-gp Mediated Drug-Drug Interactions (DDIs) of Dabigatran Co-Administered with Pharmacokinetic Enhancers in Patients with Renal Impairment. Clinical Pharmacology & Therapeutics. 2020
- Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism. Journal of thrombosis and thrombolysis (Dordrecht. Online). 1-11. 2020
- Breaking the rules for studies using real-world observational data: the case of direct-acting anticoagulants and antiepileptic drugs. European heart journal. Cardiovascular pharmacotherapy (Online). 155-156. 2020
- Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation. Journal of Clinical Pharmacology. 722-733. 2020
- Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function. JAMA Network Open. e203593. 2020
- Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy. Peritoneal dialysis international (Online). 896860819889774. 2020
- Machine learning in drug discovery and development part 1 - a primer. CPT: pharmacometrics & systems pharmacology. 2020
- Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation. 2020
- Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism. Journal of thrombosis and thrombolysis (Dordrecht. Online). 2020
- Co- expression of human hepatic uridine diphosphate glucuronosyltransferase (UGT) proteins: Implications for ontogenetic mechanisms and isoform co-regulation. Journal of Clinical Pharmacology. 2020
- Physiologically-Based Pharmacokinetic (PBPK) Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim. Frontiers in Pharmacology. 2020
- Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation. 2020
- Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children. Journal of Clinical Pharmacology. 2019
- Clinical Pharmacology Education - The Decade Ahead. Clinical Pharmacology & Therapeutics. 2019
- Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of Acetaminophen. Journal of Clinical Pharmacology. 2019
- Integrating drug- and formulation-related properties with gastrointestinal tract variability using a product-specific particle size approach: case example ibuprofen. Journal of Pharmaceutical Sciences. 2019
- Evaluating the Clinical Impact of Formulation Variability: A Metoprolol Extended-Release Case Study. Journal of Clinical Pharmacology. 1266-1274. 2019
- Physiologically Based Pharmacokinetic Modeling to Evaluate Formulation Factors Influencing Bioequivalence of Metoprolol Extended-Release Products. Journal of Clinical Pharmacology. 2019
- Real-World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution: A Metoprolol Extended-Release Case Study. Journal of Clinical Pharmacology. 2019
- Hartmut Derendorf's work on tissue distribution. European Journal of Pharmaceutical Sciences. 2019
- Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population. European Journal of Pharmaceutical Sciences. 2019
- Bioequivalence Established Based on the Reference-Scaled Average Bioequivalence Approach Relevant to Chronic Administration of Phenytoin?: Perspectives based on Population Pharmacokinetic Modeling and Simulations. Journal of Clinical Pharmacology. 59:1061-1069. 2019
- Biomarkers for Personalized Medicine in Oncology: A Work in Progress. AAPS Newsmagazine. 2019
- Characterization of the Ontogeny of Hepatic UDP-Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes. Journal of Clinical Pharmacology. 59:S42-S55. 2019
- Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis. Antimicrobial Agents and Chemotherapy. 63. 2019
- Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay. Antimicrobial Agents and Chemotherapy. 2019
- Genotype-tailored treatment of mild symptomatic acid reflux in children with uncontrolled asthma. Contemporary Clinical Trials. 78:27-33. 2019
- Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome. Therapeutic advances in cardiovascular disease (Online). 2019
- Introduction: An Integrated Bioinformatics and Quantitative Modeling Approach to Investigate Potential Claims of Oral Generic Drug Product Bioinequivalence. Journal of Clinical Pharmacology. 59:1245-1248. 2019
- Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences. CPT: pharmacometrics & systems pharmacology. 8:878-882. 2019
- Optimization of Experimental Conditions of Automated Glucuronidation Assays in Human Liver Microsomes Using a Cocktail Approach and Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry. Drug metabolism and disposition: the biological fate of chemicals. 47:124-134. 2019
- Pharmacometrics, PBPK, QSP - What's Next? - Joining Mechanistic and Epidemiological Approaches. CPT: pharmacometrics & systems pharmacology. 8:352-355. 2019
- Reproducibility of Quantitative Systems Pharmacology (QSP) Models: Current Challenges and Future Opportunities. CPT: pharmacometrics & systems pharmacology. 8:205-210. 2019
- Towards Regulatory Endorsement of Drug Development Tools to Promote the Application of Model-Informed Drug Development in Duchenne Muscular Dystrophy. Journal of Pharmacokinetics and Pharmacodynamics. 46:441-455. 2019
- Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults. Clinical Pharmacology & Therapeutics. 957-965. 2018
- Development and Qualification of a Drug-Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials. Clinical Pharmacology & Therapeutics. 104:699-708. 2018
- A Semi-Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy. CPT: pharmacometrics & systems pharmacology. 7:581-592. 2018
- Non-Procrustean Pathways for Complex Generic Drugs Development. Therapeutic Delivery. 9:605-607. 2018
- Effect of Linezolid Plus Bedaquiline Against Mycobacterium Tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in An in Vitro Assay. Antimicrobial Agents and Chemotherapy. 62. 2018
- Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations 2018
- Model Informed Dose Optimization of Dichloroacetate for the Treatment of Congenital Lactic Acidosis in Children 2018
- Activity of Moxifloxacin against Acid-Phase and Nonreplicative Persister Phenotype Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 62. 2018
- Current strategies to streamline pharmacotherapy for older adults. European Journal of Pharmaceutical Sciences. 111:432-442. 2018
- Linezolid kills acid phase and non-replicative persister phase Mycobacterium tuberculosis in a hollow fiber infection model. Antimicrobial Agents and Chemotherapy. 62. 2018
- Massgeschneidert - Die Pharmakogenetik ebnet den Weg für erfolgreiche individualisierte Interventionen. Deutsche Apotheker Zeitung. 2018
- Population pharmacokinetic modeling to establish the role of P-glycoprotein on ciprofloxacin distribution to lung and prostate following intravenous and intratracheal administration to Wistar rats. European Journal of Pharmaceutical Sciences. 127:319-329. 2018
- Regulatory perspectives in pharmacometric models of osteoporosis. Journal of Clinical Pharmacology. 58:572-585. 2018
- Establishing a multidisciplinary framework to study drug-drug interactions of hormonal contraceptives: an invitation to collaborate.. CPT: pharmacometrics & systems pharmacology. 2018
- The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling.. Clinical pharmacokinetics. 2018
- Genotype-guided dosing of warfarin through modeling and simulation. European Journal of Pharmaceutical Sciences. 2017
- Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac. Aaps Journal. 1814-1825. 2017
- Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real-World Setting: a Proposal for a New Pharmacogenetic Dosing Approach. Clinical Pharmacology & Therapeutics. 101:675-683. 2017
- Development and Qualification of Physiologically Based Pharmacokinetic Models for Drugs With Atypical Distribution Behavior: a Desipramine Case Study 2017
- Analysis of a Complex Physiology-Directed Model for Inhibition of Platelet Aggregation By Clopidogrel. Discrete and Continuous Dynamical Systems. 37:945-961. 2017
- Identifying Clinically Relevant Sources of Variability: the Clopidogrel Challenge. Clinical Pharmacology & Therapeutics. 101:264-273. 2017
- Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections. Pharmacogenetics and Genomics. 27:190-196. 2017
- How Informative Are Drug-Drug Interactions of Gene-Drug Interactions? 2016
- Development of a Mechanism-Based Pharmacokinetic/Pharmacodynamic Model to Characterize the Thermoregulatory Effects of Serotonergic Drugs in Mice. Acta Pharmaceutica Sinica B. 6:492-503. 2016
- Population Pharmacokinetic Modeling of Etoposide Free Concentrations in Solid Tumor. Pharmaceutical Research. 33:1657-1670. 2016
- Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate to Describe the Influence of Efflux Transporters on Drug Distribution Following Intravenous and Intratracheal Administration 2016
- Development of a Physiology-Directed Population Pharmacokinetic and Pharmacodynamic Model for Characterizing the Impact of Genetic and Demographic Factors on Clopidogrel Response in Healthy Adults. European Journal of Pharmaceutical Sciences. 82:64-78. 2016
- Evaluation of Changes in Oral Drug Absorption in Preterm and Term Neonates for Biopharmaceutics Classification System (Bcs) Class I and II Compounds. British Journal of Clinical Pharmacology. 81:137-147. 2016
- Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review. Journal of Clinical Pharmacology. 2015
- Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel. Clinical Pharmacokinetics. 54:147-166. 2015-02-01
- A simultaneous semi-mechanistic population analysis of levofloxacin in plasma, lung and prostate to describe the influence of efflux transporters on drug distribution following intravenous and intratracheal administration. Antimicrobial Agents and Chemotherapy. 60:946-954. 2015
- Sobol sensitivity analysis: a tool to guide the development and evaluation of systems pharmacology models. CPT: pharmacometrics & systems pharmacology. 2015
- Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects. Antimicrobial Agents and Chemotherapy. 2014
- Clinical Implementation of Genetic Testing in Medicine: a Us Regulatory Science Perspective. British Journal of Clinical Pharmacology. 77:606-611. 2014-04-01
- A Semi-Physiological Population Pharmacokinetic/Pharmacodynamic Model for the Development of a Bedside-Ready Dosing Algorithm for Clopidogrel.. Clinical Pharmacology & Therapeutics. 95:S102. 2014-03-01
- Reduced Subcutaneous Tissue Distribution of Cefazolin in Morbidly Obese Versus Non-Obese Patients Determined Using Clinical Microdialysis. Journal of Antimicrobial Chemotherapy. 69:715-723. 2014-03-01
- Model-based assessment of dosing strategies in children for monoclonal antibodies exhibiting target-mediated drug disposition. CPT: pharmacometrics & systems pharmacology. 1:e138. 2014
- Application of Pharmacokinetic/Pharmacodynamic Modelling and Simulation for the Prediction of Target Attainment of Ceftobiprole Against Meticillin-Resistant Staphylococcus Aureus Using Minimum Inhibitory Concentration and Time-Kill Curve Based Approaches. International Journal of Antimicrobial Agents. 43:60-67. 2014-01-01
- When is protein binding important?. Journal of Pharmaceutical Sciences. 2013
- Systems Approaches in Risk Assessment. Clinical Pharmacology & Therapeutics. 93:413-424. 2013-05-01
- Application of a Mechanism-Based Disease Systems Model for Osteoporosis To Clinical Data. Journal of Pharmacokinetics and Pharmacodynamics. 40:143-156. 2013-04-01
- Importance of Relating Efficacy Measures To Unbound Drug Concentrations for Anti-Infective Agents. Clinical Microbiology Reviews. 26:274-288. 2013-04-01
- A negative feedback model for a mechanism based description of longitudinal observations: application for bone turnover markers. Methods of Information in Medicine. 52:484-493. 2013
- Application of physiologically-based pharmacokinetic modeling to predict acetaminophen metabolism & pharmacokinetics in children. CPT: pharmacometrics & systems pharmacology. 2013
- Individualization of Drug Therapy: History, Present State, and Opportunities for the Future. Clinical Pharmacology & Therapeutics. 92:458-466. 2012-10-01
- Coping with time scales in disease systems analysis: application to bone remodeling. Journal of Pharmacokinetics and Pharmacodynamics. 38:873-900. 2011
- Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects. British Journal of Clinical Pharmacology. 71:886-898. 2011
- Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics. Journal of Pharmaceutical Sciences. 99:1107-1122. 2010-03-01
- Underdosing of Ertapenem in Critically Ill Patients With Pneumonia Confirmed By Monte Carlo Simulations. International Journal of Antimicrobial Agents. 35:96-97. 2010-01-01
- Pharmacokinetic-Pharmacodynamic Modeling of the in Vitro Activities of Oxazolidinone Antimicrobial Agents Against Methicillin-Resistant Staphylococcus Aureus 2009-12-01
- Effects of Plasma Protein Binding On Half-Life of Elimination 2009-09-01
- Pharmacokinetic/Pharmacodynamic Modelling and in Vitro Simulation of Dynamic Voriconazole-Candida Interactions. International Journal of Antimicrobial Agents. 34:240-245. 2009-09-01
- Soft Tissue Penetration of Cefuroxime Determined By Clinical Microdialysis in Morbidly Obese Patients Undergoing Abdominal Surgery. International Journal of Antimicrobial Agents. 34:231-235. 2009-09-01
- Ceftobiprole: a Novel Cephalosporin With Activity Against Gram-Positive and Gram-Negative Pathogens, Including Methicillin-Resistant Staphylococcus Aureus (Mrsa). International Journal of Antimicrobial Agents. 34:1-7. 2009-07-01
- Soft-Tissue Penetration of Ceftobiprole in Healthy Volunteers Determined By in Vivo Microdialysis 2009-07-01
- Clinical Pharmacokinetics and Pharmacodynamics of Tigecycline. Clinical Pharmacokinetics. 48:575-584. 2009-01-01
- Effect of Protein Binding On the Pharmacological Activity of Highly Bound Antibiotics 2008-11-01
- Pk/Pd: New Insights for Antibacterial and Antiviral Applications. Current Opinion in Pharmacology. 8:549-556. 2008-10-01
- Combination of Clinical Microdialysis and in Vitro Pharmacodynamics for Dose Optimization of Beta-Lactam Antibiotics 2008-09-01
- Soft Tissue Penetration of Cefuroxime Determined By Clinical Microdialysis in Six Obese Patients Undergoing Abdominal Surgery 2008-09-01
- A Pharmacokinetic/Pharmacodynamic Mathematical Model Accurately Describes the Activity of Voriconazole Against Candida Spp. in Vitro. International Journal of Antimicrobial Agents. 31:369-374. 2008-04-01
- Clinical Microdialysis in Skin and Soft Tissues: An Update 2008-03-01
- Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents - minimum inhibitory concentration versus time-kill curves. Expert Opinion On Drug Discovery. 2007
- Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains. International Journal of Antimicrobial Agents. 29:263-270. 2007
- Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis. Journal of Antimicrobial Chemotherapy. 2006
-
editorial article
- Tribute to Professor Hartmut Derendorf-1953 to 2020: The gentle giant of quantitative clinical pharmacology. Journal of Pharmacokinetics and Pharmacodynamics. 2021
-
review
- Regulatory Perspectives in Pharmacometric Models of Osteoporosis. 572-585. 2018
- A Comprehensive Review of Novel Drug-Disease Models in Diabetes Drug Development. Clinical Pharmacokinetics. 769-788. 2016
Research
principal investigator on
- In Silico Clinical Trial Qualification of Successful Biomarker Measurements Related to Momoclonal Antibody Drug.. awarded by Janssen Research and Development 2015 - 2017
- In Silico Modeling of Biomarkers and Surrogate Endpoints of Diabetes awarded by Lilly USA 2013 - 2015
- Population Pharmacokinetic Assessment of Lomitapide Exposurein Subjects Following Administration of Development and awarded by Aegerion Pharmaceuticals 2014
- Parameterization and Qualification of Physiologically Based Pharmaconkinetic Models in Children for Implementation in .. awarded by Simulations Plus 2013 - 2014
- Population Pharmacokinetic Assessment of Limitapide in Japanese and Caucasian Volunteers awarded by Aegerion Pharmaceuticals 2013
- Pharmacokinetic Modeling of Oral Drug Absorption in Preterm awarded by Bayer Technology Services 2013
- Aegerion Pharmaceuticals, Inc. (Project 733Pc0028) awarded by Aegerion Pharmaceuticals 2012 - 2013
investigator on
Teaching
teaching activities
Service
professional service activities
- Graduate Advisory Committee for Naveen Mangal Chair 2014 -
- Graduate Advisory Committee for Sibo Jiang Chair 2014 -
- Graduate Advisory Committee for Jiexin Deng Chair 2013 -
Contact
full name
- Stephan Schmidt
- Stephan Schmidt
- Stephan Schmidt
- Stephan Schmidt
- Stephan Schmidt
- Stephan Schmidt
- Stephan Schmidt
- Stephan Schmidt
primary email
- sschmidt@cop.ufl.edu
phone
- (407) 313-7012
fax
- (407) 313-7030
Publications in VIVO
- Contact Info
- (407) 313-7012